These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 22425643)

  • 1. Tumor-associated neutrophils: friend or foe?
    Fridlender ZG; Albelda SM
    Carcinogenesis; 2012 May; 33(5):949-55. PubMed ID: 22425643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.
    Dumitru CA; Lang S; Brandau S
    Semin Cancer Biol; 2013 Jun; 23(3):141-8. PubMed ID: 23485549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated neutrophils: new targets for cancer therapy.
    Gregory AD; Houghton AM
    Cancer Res; 2011 Apr; 71(7):2411-6. PubMed ID: 21427354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
    Moses K; Brandau S
    Semin Immunol; 2016 Apr; 28(2):187-96. PubMed ID: 27067179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth.
    Tazzyman S; Niaz H; Murdoch C
    Semin Cancer Biol; 2013 Jun; 23(3):149-58. PubMed ID: 23410638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophils as active regulators of the immune system in the tumor microenvironment.
    Shaul ME; Fridlender ZG
    J Leukoc Biol; 2017 Aug; 102(2):343-349. PubMed ID: 28264904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the cytokines produced by human neutrophils in tumors.
    Tecchio C; Scapini P; Pizzolo G; Cassatella MA
    Semin Cancer Biol; 2013 Jun; 23(3):159-70. PubMed ID: 23410636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophils: important contributors to tumor progression and metastasis.
    Swierczak A; Mouchemore KA; Hamilton JA; Anderson RL
    Cancer Metastasis Rev; 2015 Dec; 34(4):735-51. PubMed ID: 26361774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?
    Brandau S; Moses K; Lang S
    Semin Cancer Biol; 2013 Jun; 23(3):171-82. PubMed ID: 23459190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression.
    Piccard H; Muschel RJ; Opdenakker G
    Crit Rev Oncol Hematol; 2012 Jun; 82(3):296-309. PubMed ID: 21798756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils.
    Fridlender ZG; Sun J; Mishalian I; Singhal S; Cheng G; Kapoor V; Horng W; Fridlender G; Bayuh R; Worthen GS; Albelda SM
    PLoS One; 2012; 7(2):e31524. PubMed ID: 22348096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor associated macrophages and neutrophils in tumor progression.
    Galdiero MR; Garlanda C; Jaillon S; Marone G; Mantovani A
    J Cell Physiol; 2013 Jul; 228(7):1404-12. PubMed ID: 23065796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment.
    Kim J; Bae JS
    Mediators Inflamm; 2016; 2016():6058147. PubMed ID: 26966341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy.
    Kim R; Emi M; Tanabe K; Uchida Y; Toge T
    Cancer; 2004 Jun; 100(11):2281-91. PubMed ID: 15160330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression.
    Mishalian I; Bayuh R; Levy L; Zolotarov L; Michaeli J; Fridlender ZG
    Cancer Immunol Immunother; 2013 Nov; 62(11):1745-56. PubMed ID: 24092389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-35 induces N2 phenotype of neutrophils to promote tumor growth.
    Zou JM; Qin J; Li YC; Wang Y; Li D; Shu Y; Luo C; Wang SS; Chi G; Guo F; Zhang GM; Feng ZH
    Oncotarget; 2017 May; 8(20):33501-33514. PubMed ID: 28432279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors.
    Souto JC; Vila L; BrĂș A
    Med Res Rev; 2011 May; 31(3):311-63. PubMed ID: 19967776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neutrophils as tumor microenviroment member].
    Danilova AB; Baldueva IA
    Vopr Onkol; 2016; 62(1):35-44. PubMed ID: 30444330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neutrophil: foe or friend?].
    Dumas A; Pouliot M
    Med Sci (Paris); 2009; 25(8-9):699-704. PubMed ID: 19765383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.